Evidence check: Mikrobiom Test in the context of blood sugar

The link between gut microbiome and blood sugar is scientifically plausible: short-chain fatty acids (SCFAs) from fiber improve insulin sensitivity, and certain bacteria (e.g., Akkermansia muciniphila) are associated with better metabolic health. However, a commercial microbiome test for blood sugar optimization is not a validated medical tool. Most tests report relative abundances of bacterial strains but lack causal dietary guidance. Studies like Zeevi et al. (2015) show that personalized nutrition based on microbiome and glucose responses can work – but under controlled conditions with continuous glucose monitoring (CGM). A standalone stool test without dynamic measurement has limited predictive value. Long-term data are lacking, and individual variability is high. Evidence: human-moderate (association studies, small intervention trials) / marketing (test utility often overstated). Safety note: Not a medical diagnosis; prioritize physician care for diabetes or prediabetes.